Johnson & Johnson, founded in 1886, makes and sells medical devices, pharmaceuticals, and consumer health products. Headquartered in New Brunswick, N.J., the company operates over 250 subsidiary ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

The purchase is one of several transactions in recent years to boost its pharmaceuticals and medical devices units ... wield substantial influence. Johnson & Johnson, a multinational corporation known ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Johnson & Johnson (JNJ) researches, develops, manufactures, and sells various products in the healthcare field and operates through pharmaceuticals, medical devices, and consumer products divisions.

In a report released today, Tim Anderson from Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research ...

The global bone growth products market report includes exclusive data on 30 vendors. The market is highly competitive, with global players like Medtronic, Johnson & Johnson, Stryker, and Zimmer ...

Johnson & Johnson (JNJ ... world's biggest maker of health care products have depreciated by 7.4% over the course of the past month, underperforming the Medical sector's loss of 7.03% and the ...

In the latest trading session, Johnson & Johnson (JNJ ... world's biggest maker of health care products has risen by 0.15% in the past month, leading the Medical sector's loss of 2.46% and ...